Construction and characterization of bispecific costimulatory molecules containing a minimized CD86 (B7-2) domain and single-chain antibody fragments for tumor targeting

Clinical Cancer Research

Volumn 6, Issue 11, 2000, Pages 4314-4322

  Rohrbach, Florian ^a   Gerstmayer, Bernhard ^b   Biburger, Markus ^a   Wels, Winfried ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b Memorec Biotec GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; LYMPHOCYTE ACTIVATION; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNOLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; CHO CELLS; CRICETINAE; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEOPLASMS; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS;

EID: 0033748789     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors
2. The bioloy of erbB-2/neu/HER-2 and its role in cancer
3. The type 1 growth factor receptor family: New ligands and receptors and their role in breast cancer
4. Therapeutic application of anti-growth factor receptor antibodies
5. EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins
6. Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors
7. Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells
8. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies
9. Costimulation of T cell proliferation by a chimeric B7-2 antibody fusion protein specifically targeted to cells expressing the erbB2 proto-oncogene
10. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
11. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response
12. CD28/B7 system of T cell costimulation
13. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
14. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells
15. Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules
16. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules
17. Construction and expression in the yeast Pichia pastoris of functionally active soluble forms of the human costimulatory molecules B7-1 and B7-2 and the B7 counter-receptor CTLA-4
18. Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells
19. Construction and functional characterization of scFv(14E1)-ETA - A novel, highly potent antibody-toxin specific for the EGF receptor
20. Protocol for efficient secretion of HSA developed from Pichia pastoris
21. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product
22. Functional antibody single-chain fragments from the cytoplasm of Escherichia coli: Influence of thioredoxin reductase (TrxB)
23. Identification of a monoclonal antibody specific for a murine T3 polypeptide
24. B70 antigen is a second ligand for CTLA-4 and CD28
25. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
26. Genomic organization of the gene coding for the costimulatory human B-lymphocyte antigen B7-2 (CD86)
27. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion
28. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation
29. Cross-reactivity of the monoclonal antibody 9E10 with murine c-MYC
30. CD28 ligation in T-cell activation: Evidence for two signal transduction pathways
31. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
32. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation
33. Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80)
34. Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28
35. Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49
36. A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway
37. Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins